Complete Genomics to Sequence 100 Human Genomes for ISB-Led Huntington's Disease Study

The study is the first for which Complete Genomics will sequence 100 genomes at its recently expanded sequencing facility. Up until now, the company has been conducting smaller-scale pilot studies, involving five to 10 genomes, for more than a dozen customers.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.